Clinical trial
An Open-label, Single-arm, Phase 2 Study of ORL-1B in Patients With Biotinidase Deficiency
NCT03269045 is registered in ClinicalTrials.gov with Orpha Labs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Single-arm, Phase 2 Study of ORL-1B in Patients With Biotinidase Deficiency
- Lead sponsor
- Orpha Labs
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- January 1, 2018
- Enrollment
- 20 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.